Literature DB >> 27941249

Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Lisa C Burnett, Charles A LeDuc, Carlos R Sulsona, Daniel Paull, Richard Rausch, Sanaa Eddiry, Jayne F Martin Carli, Michael V Morabito, Alicja A Skowronski, Gabriela Hubner, Matthew Zimmer, Liheng Wang, Robert Day, Brynn Levy, Ilene Fennoy, Beatrice Dubern, Christine Poitou, Karine Clement, Merlin G Butler, Michael Rosenbaum, Jean Pierre Salles, Maithe Tauber, Daniel J Driscoll, Dieter Egli, Rudolph L Leibel.   

Abstract

Prader-Willi syndrome (PWS) is caused by a loss of paternally expressed genes in an imprinted region of chromosome 15q. Among the canonical PWS phenotypes are hyperphagic obesity, central hypogonadism, and low growth hormone (GH). Rare microdeletions in PWS patients define a 91-kb minimum critical deletion region encompassing 3 genes, including the noncoding RNA gene SNORD116. Here, we found that protein and transcript levels of nescient helix loop helix 2 (NHLH2) and the prohormone convertase PC1 (encoded by PCSK1) were reduced in PWS patient induced pluripotent stem cell-derived (iPSC-derived) neurons. Moreover, Nhlh2 and Pcsk1 expression were reduced in hypothalami of fasted Snord116 paternal knockout (Snord116p-/m+) mice. Hypothalamic Agrp and Npy remained elevated following refeeding in association with relative hyperphagia in Snord116p-/m+ mice. Nhlh2-deficient mice display growth deficiencies as adolescents and hypogonadism, hyperphagia, and obesity as adults. Nhlh2 has also been shown to promote Pcsk1 expression. Humans and mice deficient in PC1 display hyperphagic obesity, hypogonadism, decreased GH, and hypoinsulinemic diabetes due to impaired prohormone processing. Here, we found that Snord116p-/m+ mice displayed in vivo functional defects in prohormone processing of proinsulin, pro-GH-releasing hormone, and proghrelin in association with reductions in islet, hypothalamic, and stomach PC1 content. Our findings suggest that the major neuroendocrine features of PWS are due to PC1 deficiency.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27941249      PMCID: PMC5199710          DOI: 10.1172/JCI88648

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  Posttranslational processing of progrowth hormone-releasing hormone.

Authors:  E A Nillni; R Steinmetz; O H Pescovitz
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

2.  Birth prevalence of Prader-Willi syndrome in Australia.

Authors:  A Smith; J Egan; G Ridley; E Haan; P Montgomery; K Williams; E Elliott
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

3.  Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms.

Authors:  Giles S H Yeo; Emma J Lank; I Sadaf Farooqi; Julia Keogh; Benjamin G Challis; Stephen O'Rahilly
Journal:  Hum Mol Genet       Date:  2003-03-01       Impact factor: 6.150

4.  Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3.

Authors:  John W M Creemers; Lynn E Pritchard; Amy Gyte; Philippe Le Rouzic; Sandra Meulemans; Sharon L Wardlaw; Xiaorong Zhu; Donald F Steiner; Nicola Davies; Duncan Armstrong; Catherine B Lawrence; Simon M Luckman; Catherine A Schmitz; Rick A Davies; John C Brennand; Anne White
Journal:  Endocrinology       Date:  2005-12-29       Impact factor: 4.736

5.  A simple role for BDNF in learning and memory?

Authors:  Carla Cunha; Riccardo Brambilla; Kerrie L Thomas
Journal:  Front Mol Neurosci       Date:  2010-02-09       Impact factor: 5.639

6.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.

Authors:  Xiaorong Zhu; An Zhou; Arunangsu Dey; Christina Norrbom; Raymond Carroll; Chunling Zhang; Virginie Laurent; Iris Lindberg; Randi Ugleholdt; Jens J Holst; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

Review 7.  Mouse models of Prader-Willi Syndrome: a systematic review.

Authors:  Sandrina Bervini; Herbert Herzog
Journal:  Front Neuroendocrinol       Date:  2013-02-04       Impact factor: 8.606

Review 8.  Regulation of prohormone convertases in hypothalamic neurons: implications for prothyrotropin-releasing hormone and proopiomelanocortin.

Authors:  Eduardo A Nillni
Journal:  Endocrinology       Date:  2007-06-21       Impact factor: 4.736

9.  Early onset obesity and adrenal insufficiency associated with a homozygous POMC mutation.

Authors:  Meenal S Mendiratta; Yaping Yang; Andrea E Balazs; Alecia S Willis; Christine M Eng; Lefkothea P Karaviti; Lorraine Potocki
Journal:  Int J Pediatr Endocrinol       Date:  2011-07-06

10.  Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance.

Authors:  Anthony P Goldstone; E Louise Thomas; Audrey E Brynes; Gabriela Castroman; Ray Edwards; Mohammad A Ghatei; Gary Frost; Anthony J Holland; Ashley B Grossman; Márta Korbonits; Stephen R Bloom; Jimmy D Bell
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

View more
  49 in total

Review 1.  GENETIC AND EPIGENETIC CAUSES OF OBESITY.

Authors:  Vidhu V Thaker
Journal:  Adolesc Med State Art Rev       Date:  2017

Review 2.  Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.

Authors:  Antonino Crinò; Graziano Grugni
Journal:  Curr Diab Rep       Date:  2020-02-06       Impact factor: 4.810

3.  Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome.

Authors:  Elisabeth M Dykens; Jennifer Miller; Moris Angulo; Elizabeth Roof; Michael Reidy; Hind T Hatoum; Richard Willey; Guy Bolton; Paul Korner
Journal:  JCI Insight       Date:  2018-06-21

Review 4.  Ghrelin as a Survival Hormone.

Authors:  Bharath K Mani; Jeffrey M Zigman
Journal:  Trends Endocrinol Metab       Date:  2017-10-30       Impact factor: 12.015

Review 5.  Epigenetic therapy of Prader-Willi syndrome.

Authors:  Yuna Kim; Sung Eun Wang; Yong-Hui Jiang
Journal:  Transl Res       Date:  2019-03-05       Impact factor: 7.012

6.  Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: the buck stops here?

Authors:  Juan A Rodriguez; Jeffrey M Zigman
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

7.  Specific ZNF274 binding interference at SNORD116 activates the maternal transcripts in Prader-Willi syndrome neurons.

Authors:  Maéva Langouët; Dea Gorka; Clarisse Orniacki; Clémence M Dupont-Thibert; Michael S Chung; Heather R Glatt-Deeley; Noelle Germain; Leann J Crandall; Justin L Cotney; Christopher E Stoddard; Marc Lalande; Stormy J Chamberlain
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

8.  Reduced Stability and pH-Dependent Activity of a Common Obesity-Linked PCSK1 Polymorphism, N221D.

Authors:  Timothy S Jarvela; Manita Shakya; Tomas Bachor; Anne White; Malcolm J Low; Iris Lindberg
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

9.  Loss of the imprinted, non-coding Snord116 gene cluster in the interval deleted in the Prader Willi syndrome results in murine neuronal and endocrine pancreatic developmental phenotypes.

Authors:  Lisa Cole Burnett; Gabriela Hubner; Charles A LeDuc; Michael V Morabito; Jayne F Martin Carli; Rudolph L Leibel
Journal:  Hum Mol Genet       Date:  2017-12-01       Impact factor: 6.150

10.  Autoimmune pituitary involvement in Prader-Willi syndrome: new perspective for further research.

Authors:  Graziano Grugni; Antonino Crinò; Annamaria De Bellis; Alessio Convertino; Sarah Bocchini; Sabrina Maestrini; Paolo Cirillo; Silvana De Lucia; Maurizio Delvecchio
Journal:  Endocrine       Date:  2018-07-02       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.